drugset / Trial / NCT03596073

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

NCT03596073

Phase 1 Terminated 43 enrolled Massachusetts General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This research study is studying a topical ointment called calcipotriene to see if it can stimulate the immune cells against the breast lesion in ways that would prevent its recurrence after surgical removal

Timeline

Start
2018-11-07
Primary completion
2020-08-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical

Indications